Market Cap (In SEK)
134.99 Million
Revenue (In SEK)
43.03 Million
Net Income (In SEK)
-59.29 Million
Avg. Volume
224.71 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.301-0.66
- PE
- -3.26
- EPS
- -0.18
- Beta Value
- 1.267
- ISIN
- SE0003883990
- CUSIP
- -
- CIK
- -
- Shares
- 230361000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Anders Hultman B.Sc.
- Employee Count
- -
- Website
- https://www.arocell.com
- Ipo Date
- 2011-05-25
- Details
- AroCell AB (publ), a vitro diagnostics company, focuses on monitoring of hematological malignancies, breast cancer, and other solid tumors. The company develops, manufactures, and sells AroCell TK 210 ELISA, an immunoassay kit for the determination of Thymidine Kinase 1 in human blood. It also offers TUBEX TF, a bacteriological rapid test for diagnosis of typhoid fever. The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006. AroCell AB (publ) was incorporated in 2000 and is based in Uppsala, Sweden.
More Stocks
-
064550Bioneer Corporation
064550
-
EVGIF
-
002821
-
GATEWAYGateway Distriparks Limited
GATEWAY
-
LNT
-
6698
-
603861
-
FTII